Pharmacokinetics and pharmacodynamics of intranasal remimazolam—a randomized controlled clinical trial

PURPOSE: Remimazolam is a novel and ultra-short-acting sedative currently developed for intravenous use in procedural sedation, general anesthesia, and ICU sedation. However, intravenous administration is not always appropriate, depending on the patient or setting. This study evaluated intranasal ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Pesic, Marija, Schippers, Frank, Saunders, Rob, Webster, Lyn, Donsbach, Martin, Stoehr, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Pharmacodynamics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557484/
https://www.ncbi.nlm.nih.gov/pubmed/32886178
http://dx.doi.org/10.1007/s00228-020-02984-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557484/
https://www.ncbi.nlm.nih.gov/pubmed/32886178
http://dx.doi.org/10.1007/s00228-020-02984-z

Ejemplares similares